Quarterly report pursuant to Section 13 or 15(d)

Segment Information

v3.23.3
Segment Information
 9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Segment Information Segment Information
During the nine months ended September 30, 2023, the Company renamed its Industrial segment as "Technologies."
Beginning January 1, 2023, the Company began measuring segment performance to include the impact of expenses identified as non-operating. Previously, these expenses would have been included with Corporate and other. Segment income (loss) from operations for the three and nine months ended September 30, 2022 has been adjusted for comparability.
The following table summarizes select operating results for each reportable segment (in millions).
Three Months Ended September 30, Three Months Ended September 30, Nine Months Ended September 30, Nine Months Ended September 30,
2023 2022 2023 2022
Revenues
Medical $ 68.8  $ 68.7  $ 203.2  $ 195.6 
Technologies 122.4  92.2  367.3  304.3 
Consolidated Revenues $ 191.2  $ 160.9  $ 570.5  $ 499.9 
Segment Income (Loss) from Operations
Medical $ 4.0  $ (3.5) $ 1.6  $ (12.4)
Technologies 5.4  (3.3) 23.7  (52.3)
Total Segment Income (Loss) from Operations 9.4  (6.8) 25.3  (64.7)
Corporate and other (20.5) (20.8) (60.6) (71.2)
Consolidated Loss from Operations $ (11.1) $ (27.6) $ (35.3) $ (135.9)
The Company’s assets by reportable segment were not included, as this information is not reviewed by, nor otherwise provided to, the chief operating decision maker to make operating decisions or allocate resources.
The following details revenues by geographic region. Revenues generated from external customers are attributed to geographic regions through sales from site locations (i.e., point of origin) (in millions).
Revenues
Three Months Ended September 30, Three Months Ended September 30, Nine Months Ended September 30, Nine Months Ended September 30,
2023 2022 2023 2022
North America
Medical $ 62.1  $ 63.7  $ 185.0  $ 181.0 
Technologies 69.8  49.7  189.1  141.8 
Total North America 131.9  113.4  374.1  322.8 
Europe
Medical 6.7  5.1  18.2  14.7 
Technologies 50.7  40.9  167.2  152.0 
Total Europe 57.4  46.0  185.4  166.7 
Asia Pacific
Medical —  —  —  — 
Technologies 1.9  1.5  11.0  10.4 
Total Asia Pacific 1.9  1.5  11.0  10.4 
Total revenues $ 191.2  $ 160.9  $ 570.5  $ 499.9 
The following details revenues by timing of recognition (in millions):
Revenues
Three Months Ended September 30, Three Months Ended September 30, Nine Months Ended September 30, Nine Months Ended September 30,
2023 2022 2023 2022
Point in time $ 128.0  $ 88.8  $ 371.1  $ 323.0 
Over time 63.2  72.1  199.4  176.9 
Total revenues $ 191.2  $ 160.9  $ 570.5  $ 499.9 
The following details revenues by product category (in millions):
Revenues
Three Months Ended September 30, Three Months Ended September 30, Nine Months Ended September 30, Nine Months Ended September 30,
2023 2022 2023 2022
Medical segment:
Medical $ 68.8  $ 68.7  $ 203.2  $ 195.6 
Technologies segment:
Reactor Safety and Control Systems 48.7  23.7  141.9  89.2 
Radiological Search, Measurement, and Analysis Systems 73.7  68.5  225.4  215.1 
Total revenues $ 191.2  $ 160.9  $ 570.5  $ 499.9